WELLS FARGO & COMPANY/MN

Position in NVO — Novo Nordisk A S

CIK 72971 SAN FRANCISCO, CA

Back to NVO Full portfolio

Position in NVO

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$223,287,356

+$89,421,844 QoQ

Shares Held

4,657,642

+27.9% QoQ

Ownership

0.105%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#19

of 1,348 holders

Holding Since

Mar 2020

26 quarters on record

Voting authority Sole 98% Shared 0% None 2%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Derivatives in NVO

reported options exposure · as of Dec 31, 2024

CallValue

$2,150,500

CallShares

25,000

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $19,103,501,096 across 19 Drug Manufacturers - General names. NVO ranks #11 (1.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	4,646,119	$5,572,694,974
2	JNJ	Johnson & Johnson	17,374,433	$4,412,584,747
3	AMGN	Amgen Inc	7,235,462	$2,620,105,497
4	ABBV	AbbVie Inc.	9,017,580	$2,269,183,828
5	MRK	Merck & Co., Inc.	11,658,434	$1,498,108,767
6	GILD	Gilead Sciences, Inc.	6,439,586	$813,577,293
7	PFE	Pfizer Inc	20,193,675	$486,263,691
8	BMY	Bristol Myers Squibb Co	6,321,643	$364,253,067

All Filings in NVO

Export CSV

35 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$223,287,356	4,657,642	+27.9%	Shares	Defined	2026-08-14
2026-03-31	$133,865,512	3,642,599	-8.8%	Shares	Defined	2026-05-11
2025-12-31	$203,115,451	3,992,049	-2.8%	Shares	Defined	2026-02-13
2025-09-30	$227,862,079	4,106,363	-1.6%	Shares	Defined	2025-11-13
2025-06-30	$287,925,417	4,171,623	+10.0%	Shares	Defined	2025-08-14
2025-03-31	$263,372,933	3,792,813	+3.3%	Shares	Defined	2025-05-13
2024-12-31	$2,150,500	25,000	0.0%	Call	Defined	2025-02-13
2024-12-31	$315,961,350	3,673,115	-9.7%	Shares	Defined	2025-02-13
2024-09-30	$484,478,445	4,068,854	-0.4%	Shares	Defined	2024-11-13
2024-09-30	$2,976,750	25,000	0.0%	Call	Defined	2024-11-13
2024-06-30	$3,568,500	25,000	0.0%	Call	Defined	2024-08-13
2024-06-30	$583,315,002	4,086,556	+3.4%	Shares	Defined	2024-08-13
2024-03-31	$3,210,000	25,000	-34.2%	Call	Defined	2024-05-10
2024-03-31	$507,693,598	3,954,000	+4.1%	Shares	Defined	2024-05-10
2023-12-31	$3,931,100	38,000	-4.5%	Call	Defined	2024-02-09
2023-12-31	$393,032,307	3,799,249	+3.3%	Shares	Defined	2024-02-09
2023-09-30	$334,365,007	3,676,765	+120.1%	Shares	Defined	2023-11-13
2023-09-30	$3,619,412	39,800	+36.8%	Call	Defined	2023-11-13
2023-06-30	$270,349,313	1,670,576	+5.1%	Shares	Defined	2023-08-15
2023-03-31	$252,878,391	1,589,031	-0.8%	Shares	Defined	2023-05-12
2022-12-31	$216,687,187	1,601,058	-0.1%	Shares	Defined	2023-02-13
2022-09-30	$159,749,629	1,603,429	-10.3%	Shares	Defined	2022-11-14
2022-06-30	$199,160,620	1,787,316	+5.4%	Shares	Defined	2022-08-12
2022-03-31	$188,391,770	1,696,459	+11.6%	Shares	Defined	2022-05-16
2021-12-31	$170,232,384	1,519,932	-1.1%	Shares	Defined	2022-02-14
2021-09-30	$147,597,804	1,537,317	+0.8%	Shares	Defined	2021-11-15
2021-06-30	$127,802,862	1,525,640	-13.2%	Shares	Defined	2021-08-16
2021-03-31	$118,513,976	1,757,846	+5.5%	Shares	Defined	2021-05-13
2020-12-31	$116,397,410	1,666,391	+3.7%	Shares	Defined	2021-02-09
2020-12-31	$10,000	21,300	0.0%	Put	Defined	2021-02-09
2020-09-30	$111,581,298	1,607,105	+12.1%	Shares	Defined	2020-11-05
2020-09-30	$27,000	21,300	—	Put	Defined	2020-11-05
2020-06-30	$93,892,555	1,433,912	-0.6%	Shares	Defined	2020-08-13
2020-03-31	$113,000	29,100	—	Call	Defined	2020-05-14
2020-03-31	$86,880,036	1,443,190	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.